Get started
Author

Luis Alfonso Ramírez-Martínez

Observed names: L. A. Ramírez-Martínez, Luis A. Ramírez‐Martínez, Luis Alfonso Ramírez‐Martínez, Luis Ramirez-Martinez, Luis Ramírez-Martínez
ORCID: 0000-0002-9162-5721
Observed ORCID: 0000-0002-9162-5721
OpenAlex ID: A5051294140
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico
2023 · Samuel Ponce-de-León, Martha Torres, et al. · npj Vaccines · 72
PDF
Fecal virome composition of migratory wild duck species
2018 · Luis Alfonso Ramírez-Martínez, Elizabeth Loza-Rubio, et al. · PLoS ONE · 49
PDF
Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs
2021 · Jesús Horacio Lara-Puente, Juan Manuel Carreño, et al. · mBio · 46
Evidence of transmission and risk factors for influenza A virus in household dogs and their owners
2013 · Luis A. Ramírez‐Martínez, María Contreras‐Luna, et al. · Influenza and Other Respiratory Viruses · 34
PDF
Evidence of respiratory syncytial virus and parainfluenza-3 virus in Mexican sheep
2017 · M. J. Contreras-Luna, L. A. Ramírez-Martínez, et al. · VirusDisease · 20
PDF
Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico
2024 · Constantino López-Macías, Martha Torres, et al. · Vaccine · 18
Immunogenicity and Protective Efficacy of Five Vaccines Against Highly Pathogenic Avian Influenza Virus H5N1, Clade 2.3.4.4b, in Fattening Geese
2025 · Ronja Piesche, Christophe Cazaban, et al. · Vaccines · 14
PDF
Immunogenic and antigenic analysis of recombinant NSP1 and NSP11 of PRRS virus
2022 · María Josefina Contreras‐Luna, Gladis Fragoso‐Gonzalez, et al. · Veterinary Medicine and Science · 11
Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine
2025 · Constantino López-Macías, Martha Torres, et al. · Science Advances · 6
PDF
The Validation of a Hemagglutination Inhibition Assay That Detects Antibodies Against a Newcastle Disease Virus-Based Vaccine Vector in Human Serum Samples
2025 · Milton Nieto-Ponce, Edgar Reyna-Rosas, et al. · Vaccines · 3
Protective Efficacy of an Inactivated H5N8 Avian Influenza Virus Vaccine Against Highly Pathogenic Avian Influenza H5N1 Viruses Belonging to Clade 2.3.4.4b in Chickens and Ducks
2025 · Luis Ramírez-Martínez, Francesco Bonfante, et al. · Avian Diseases · 2
Phase II/III Double-Blind Study Evaluating Safety and Immunogenicity of a Single Intramuscular Booster Dose of the Recombinant SARS-CoV-2 Vaccine “Patria” (AVX/COVID-12) Using an Active Newcastle Disease Viral Vector (NDV) during the Omicron Outbreak in Healthy Adults with Elevated Baseline Antibody Titers from Prior COVID-19 and/or SARS-CoV-2 Vaccination
2024 · Constantino López-Macías, Martha Torres, et al. · medRxiv · 2
PDF
Author response for "Immunogenic and antigenic analysis of recombinant NSP1 and NSP11 of PRRS virus"
2021 · María Josefina Contreras‐Luna, Gladis Fragoso‐Gonzalez, et al. · Publons reviews and discussion
Author response for "Immunogenic and antigenic analysis of recombinant NSP1 and NSP11 of PRRS virus"
2021 · María Josefina Contreras‐Luna, Gladis Fragoso‐Gonzalez, et al. · Publons reviews and discussion
Works count: 14
Citation count: 277
H-index: 8
I10-index: 8
Year
Topic
Type